Y7N-26025-56546

3 vaccinations 11 coded responses 39 check-ins 11 free-text entries 0 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 440 / OH
Registered: 2021-03-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-06
Registered in v-safe
2021-03-06
Dose 1 — Pfizer-BioNTech
2021-03-06
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-13
Health check-in — day 7, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2021-03-20
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-27
Dose 2 — Pfizer-BioNTech
2021-03-27
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains, Muscle or body aches

Adult check-in
2021-04-03
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-10
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-17
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-01
Survey response — day 35, dose 2
MedDRA: Heavy menstrual bleeding — Feeling: Good

Free text: Had a period for the first time in approx a year (I have an IUD) and it was the heaviest it's been in years

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-08
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-26
Survey response — 3 months, dose 2
MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Good

Free text: Heavier & more painful periods

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-25
Survey response — 6 months, dose 2
MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities

Free text: Recurrent severe headaches

MedDRA releases: 2024-11 · check-in free text available
2021-11-23
Dose 3 — Pfizer-BioNTech
2021-11-24
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-25
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Swollen lymph nodes in armpit

MedDRA releases: 2024-11 · check-in free text available
2021-11-26
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Enlarged lymph nodes

MedDRA releases: 2024-11 · check-in free text available
2021-11-27
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Injection site is bruised

MedDRA releases: 2024-11 · check-in free text available
2021-11-28
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Bruising at injection site

MedDRA releases: 2024-11 · check-in free text available
2021-11-29
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site bruising — Feeling: Fair · Site: Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Severe bruising at injection site

MedDRA releases: 2024-11 · check-in free text available
2021-11-30
Survey response — day 7, dose 3
MedDRA: Injection site bruising — Feeling: Fair · Site: Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Severe bruising at injection site

MedDRA releases: 2024-11 · check-in free text available
2021-12-07
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-14
Survey response — day 21, dose 3
MedDRA: Injection site bruising, Injection site discolouration — Feeling: Fair

Free text: Worsening bruising around injection site. Blue/purple bruising slowly increasing in size

MedDRA releases: 2024-11 · check-in free text available
2021-12-21
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-28
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-04
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-22
Survey response — 3 months, dose 3
MedDRA: Diplopia, Dysarthria, Migraine, Neurological symptom — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Increasingly common and debilitating migraines including neurological symptoms such as double vision and slurred speech.

MedDRA releases: 2024-11 · check-in free text available
2022-05-24
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-23
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Pfizer-BioNTech
2	2021-03-27	Pfizer-BioNTech
3	2021-11-23	Pfizer-BioNTech	No

Free text

Release 8 — day 35, dose 2

2021-05-01

Symptoms: Had a period for the first time in approx a year (I have an IUD) and it was the heaviest it's been in years

Release 9 — 3 months, dose 2

2021-06-26

Symptoms: Heavier & more painful periods

Release 9 — 6 months, dose 2

2021-09-25

Symptoms: Recurrent severe headaches

Release 10 — days 1–6 daily, dose 3

2021-11-25

Systemic reaction (other): Swollen lymph nodes in armpit

2021-11-26

Systemic reaction (other): Enlarged lymph nodes

2021-11-27

Systemic reaction (other): Injection site is bruised

2021-11-28

Systemic reaction (other): Bruising at injection site

2021-11-29

Systemic reaction (other): Severe bruising at injection site

Release 10 — day 7, dose 3

2021-11-30

Systemic reaction (other): Severe bruising at injection site

Release 10 — day 21, dose 3

2021-12-14

Symptoms: Worsening bruising around injection site. Blue/purple bruising slowly increasing in size

Release 11 — 3 months, dose 3

2022-02-22

Symptoms: Increasingly common and debilitating migraines including neurological symptoms such as double vision and slurred speech.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diplopia	·	·	✓
SD	Dysarthria	·	·	✓
SD	Dysmenorrhoea	✓	✓	✓
SD	Headache	·	·	✓
SD	Heavy menstrual bleeding	✓	✓	✓
SD	Injection site bruising	·	·	✓
SD	Injection site discolouration	·	·	✓
SD	Migraine	·	·	✓
SD	Neurological symptom	·	·	✓
SRO	Injection site bruising	·	·	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release